Categories Annual ReportsCorporate GovernanceDefault CalendarFeatured DocumentsPresentationsProxy Statements Year None2024202320222021202020192018201720162015201420132012201120102009200820072006 Title Supernus Announces Paragraph IV ANDA Filing for Trokendi XR(R) Supernus to Attend FBR HealthCare Conference in September Supernus Receives FDA Fast Track Designation for SPN-810 Supernus Announces Second Quarter 2014 Results Supernus to Host Second Quarter 2014 Earnings Conference Call Supernus to Receive $30 Million in Non-Dilutive Royalty Deal Supernus to Present at Jefferies Healthcare Conference in June Supernus Receives $2 Million Milestone for United Therapeutics' Launch of Orenitram(TM) Supernus Announces First Quarter 2014 Results Supernus to Host First Quarter 2014 Earnings Conference Call Pagination First page « first Previous page ‹ previous … Page 11 Page 12 Page 13 Page 14 Current page 15 Page 16 Page 17 Page 18 Page 19 … Next page next › Last page last »